Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paweł Muszyński
Observed name:
Muszyński, Paweł
Institution:
Medical University of Białystok
Observed institution:
Medical University of Białystok
ORCID:
0000-0003-0974-7138
Observed ORCID:
0000-0003-0974-7138
OpenAlex ID:
A5101797663
Mitochondrial Dysfunction in Atrial Fibrillation—Mechanisms and Pharmacological Interventions
2021
·
Paweł Muszyński
, Tomasz A. Bonda
·
Journal of Clinical Medicine
·
46
PDF
Percutaneous Coronary Intervention for Chronic Total Occlusion—Contemporary Approach and Future Directions
2023
·
Emil Julian Dąbrowski
, Michał Święczkowski
, et al.
·
Journal of Clinical Medicine
·
17
PDF
Hyperuricemia as a Risk Factor in Hypertension among Patients with Very High Cardiovascular Risk
2023
·
Paweł Muszyński
, Emil Julian Dąbrowski
, et al.
·
Healthcare
·
16
PDF
A Comprehensive Review of Percutaneous and Surgical Left Atrial Appendage Occlusion
2024
·
Michał Święczkowski
, Emil Julian Dąbrowski
, et al.
·
Journal of Cardiovascular Development and Disease
·
9
Sex-Related Differences in the Prevalence of Classical, Non-Classical Risk Factors and Management of the Chronic Coronary Syndrome
2023
·
Paweł Muszyński
, Elżbieta Pawluczuk
, et al.
·
Journal of Clinical Medicine
·
9
PDF
The Influence of Empagliflozin on the Expression of Mitochondrial Regulatory Proteins in Human Myocardium in an Ex Vivo Model of Short-Term Atrial Tachypacing
2025
·
Paweł Muszyński
, Magdalena Cieślińska
, et al.
·
International Journal of Molecular Sciences
·
5
PDF
Exploring the Relationship between Acute Coronary Syndrome, Lower Respiratory Tract Infections, and Atmospheric Pollution
2024
·
Paweł Muszyński
, Elżbieta Pawluczuk
, et al.
·
Journal of Clinical Medicine
·
3
PDF
Influence of risky and protective behaviors connected with listening to music on hearing loss and the noise induced threshold shift among students of the Medical University of Bialystok
2017
·
Beata Modzelewska
, Anna Samluk
, et al.
·
Family Medicine & Primary Care Review
·
3
PDF
Severe tricuspid regurgitation: aetiology, patient characteristics, and treatment: a multicentre, prospective registry
2026
·
Agnieszka Kapłon-Cieślicka
, Adam Piasecki
, et al.
·
ESC Heart Failure
·
2
Predictors of Escalation of Lipid-Lowering Therapy with Subanalysis of the Influence of Lipoprotein (a) on the Decision-Making Process
2025
·
Paweł Muszyński
, Kinga Natalia Dudzińska
, et al.
·
Diseases
·
2
PDF
Mental Disorders as Risk Factors for New Onset Cardiovascular Diseases
2026
·
Agata Anna Sakowicz-Hriscu
, Oliwia Grunwald
, et al.
·
Biomedicines
·
1
Non-Responder to Inclisiran and Evolocumab—A Female Patient with Heterozygous Familial Hypercholesterolemia and Statin Intolerance
2026
·
Paweł Muszyński
, Małgorzata Chlabicz
, et al.
·
Diseases
·
1
PDF
“Single Coronary Artery” from Right Sinus—Uncommon Causes of Ischemia with Non-Obstructive Coronary Arteries
2025
·
Paweł Muszyński
, Marlena Święcicka
, et al.
·
Diagnostics
·
1
PDF
Distinct Determinants of Hospitalisation and In-Hospital Mortality After Acute Stroke: Insights into Stroke–Heart Syndrome (SHS-PARTICLES Study)
2026
·
Małgorzata Chlabicz
, Magdalena Krętowska
, et al.
·
Journal of Clinical Medicine
Pericardial effusion and in-hospital mortality in adults hospitalized with severe or greater tricuspid regurgitation: A multicenter registry study
2026
·
Michał Pac
, Piotr Nikodem Rudziński
, et al.
·
Kardiologia Polska
A Rare Case of Multimetastatic Choriocarcinoma
2026
·
Daria Szymaniuk
, Paula Szymaniuk
, et al.
·
Diagnostics
Non-responder to Inclisiran and Evolocumab - a Female Patient With Heterozygous Familial Hypercholesterolemia and Statin Intolerance
2026
·
Małgorzata Chlabicz
, Katarzyna Wilk-Śledziewska
, et al.
·
Atherosclerosis
A Dangerous Combination of Extremely High Concentration of Lipoprotein (a) and Familial Hypercholesterolemia - From Diagnosis to Successful Treatment.
2026
·
Paweł Muszyński
, Dorota Pura
, et al.
·
Atherosclerosis
Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome Associated With a Homozygous Mutation in the Lmf1 Gene.
2026
·
Joanna Kruszyńska
, Paweł Muszyński
, et al.
·
Atherosclerosis
Does Lp (a) Influence the Decision-making Process in Patients in Need of Escalation of Lipid Lowering Therapy?
2026
·
Paweł Muszyński
, Kinga Dudzińska
, et al.
·
Atherosclerosis
Assessment of miR-1-3p, miR-let-7b-5p, miR-21-5p, and miR-26b-5p in Children with Cardiovascular Diseases
2026
·
Marta Pasławska-Zyskowska
, Piotr Majewski
, et al.
·
Cells
PDF
A Multi-Modality Approach to the Assessment of a Right Atrium Mass in a Female Patient with Breast Cancer Undergoing Neoadjuvant Chemotherapy
2025
·
Małgorzata Chlabicz
, Paweł Muszyński
, et al.
·
Diagnostics
PDF
Sex-Related Differences in Early In-Hospital Outcome (Technical Success and Complications) of Carotid Artery Stenting and Risk Factors of Carotid Artery Stenosis
2025
·
Kinga Natalia Dudzińska
, Paweł Muszyński
, et al.
·
Diseases
PDF
Znaczenie preparatów łączonych w leczeniu zaburzeń lipidowych oraz w prewencji zdarzeń sercowo-naczyniowych
2025
·
Paweł Muszyński
, Anna Tomaszuk-Kazberuk
·
Medycyna Faktów
Ocena wpływu inhibitora SGLT-2 na metabolizm tlenowy w eksperymentalnym modelu migotania przedsionków
2025
·
Muszyński, Paweł
·
Medical University of Bialystok
Show more works
View as search
Works count:
27
Citation count:
115
H-index:
5
I10-index:
3
Year
Topic
Type